AbbVie to Present at the Leerink Partners Global Healthcare Conference
Get Alerts ABBV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
EPS Growth %: +107.5%
Join SI Premium – FREE
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: (224) 244-0111 | Investors:
|
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-leerink-partners-global-healthcare-conference-302701106.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yatsen Announces Second Quarter 2026 Financial Results
- TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program
- Thunes Champions Ethical Global Payments with its 2026 United Nations Global Compact Commitment
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share